Comparative study on resistant pattern of clinical isolates against Levofloxacin and Cefepime

Pakistan Journal of Pharmaceutical Sciences

Volumn 26, Issue 2, 2013, Pages 415-419

  Nasiri, Muhammad Iqbal ^a   Naqvi, Syed Baqir Shyum ^a   Zaidi, Aamir Ali ^a   Saeed, Rehana ^a   Raza, Ghazala ^b  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b FEDERAL URDU UNIVERSITY OF ARTS   (Pakistan)

Author keywords

Cefepime and Levofloxacin; Escherichia coli; Klebsiella pneumoniae and Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

CEFEPIME; LEVOFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISK DIFFUSION; DRUG EFFICACY; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

BACTERIA; CEPHALOSPORINS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; OFLOXACIN;

EID: 84878095103     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Adriano A (2006). Levofloxacin work well for ear infection in kids. Pediatr. Infect. Dis. J., 35: 1-49.
2. Antonio S, Jose G, Jose MR, Juan de DL, Miguel D and Gonzalo P (2007). Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli. J. Basic Microbiol., 47: 413-416.
3. Bearden David T and Danziger Larry H (2001). Mechanism of action of and resistance to quinolones. Pharmacotherapy, 21(10): 224-232.
4. Bertrand A, Leophonte P, Nouvet G, Muir JF, Lusht F, Delaval P, Depeirre A, Hughes F, Ulmer M, Gres JJ and Rollin C (1993). A comparative study of cefepime & ceftazidime in the treatment of community-acquired lower respiratory tract infections. J. Antimicrob. Chemother., 32: 165-173.
5. Jett BD, Ritchie DJ, Reichley R, Bailey TC and Sahm DF (1995). In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins. Antimicrob. Agents Chemother., 39(5): 1187-1190.
6. Blondeau JM, Laskowski R and Borsos (1999). In vitro activity of cefepime and seven other antimicrobial agents against 1518 non-fermentative Gram-negative bacilli collected from 48 Canadian health care facilities. J. Antimicrob. Chemother., 44(4): 545-548.
7. Christopher J, Harrison and Denise Bratcher (2008). Cephalosporins: A review: American Academy of Pediatrics. Pediatrics in Review, 29: 264-273.
8. Davey PG, Ledingham JGG and Warrell DA (2000). Antimicrobial Chemotherapy. Concise Oxford Textbook of Medicine. Oxford University Press, Oxford, p.1475.
9. David SB, Ronald GH and Thomas CH (2003). In vitro evaluation of the activity of two doses of Levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa. Diagn. Microbiol. Infect. Dis., 46(2): 131-137.
10. Eliopoulos GM, Wennersten CB and Moellering RC (1996). Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria. Diagn. Microbiol. Infect. Dis., 25(1): 35-41.
11. Hans HS, Mary-Claude N and Alain J (1999). Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and hematology/oncology patients in Switzerland: A multicentre study. J. Antimicrob. Chemother., 43: 51-54.
12. Joaquim R (2003). Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51: 1109-1117.
13. Jung-Chung Lin, Yeh Kuo-Ming, Ming-Yieh Peng and Feng-Yee Chang (2001). Efficacy of cefepime versus ceftazidime in the treatment of adult Pneumonia. J. Microbiol. Immunol. Infect. Dis., 34(2): 131-137.
14. Kenneth T (2008). Todayr's Online Textbook of Bacteriology. www.textbookofbacteriology.net, pp.0104.
15. Lorenzo D and Elena DV (2008). The safety of cefepime in the treatment of infection. Expert. Opin. Drug Saf., 7(4): 377-387.
16. Sader HS, Jones RN, Gales AC, Winokur P, Kugler KC, Pfaller MA and Doern GV (1998). Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group. Diagn. Microbiol. Infect. Dis., 32(4): 289-301.
17. Surapee P, Nalinee A and Busaba C (1994). In vitro activity of cefepime an extended spectrum parenteral cephalosporin in comparison with other cephalosporin. J. Infect. Dis. Antimicrob. Agents, 11: 103-106.
18. Waksman SA (1947). What is an Antibiotic or an Antibiotic Substance? Mycologia, 39(5): 565-569.
19. Wolfgang G and Markus Z (2004). Clinical application of levofloxacin for severe infections. Int. J. Exp. Clin. Chemother., 50: 16-21.